Ausgabe 3/2016
Inhalt (22 Artikel)
Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies
Philip E. Lee, Mary C. Tierney, Wei Wu, Kathleen I. Pritchard, Paula A. Rochon
Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status
Martinus A. Beek, Paul D. Gobardhan, Ernst J. P. Schoenmaeckers, Elisabeth G. Klompenhouwer, Harm J. T. Rutten, Adri C. Voogd, Ernest J. T. Luiten
Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants
Saeam Shin, In Sik Hwang, Seung-Tae Lee, Jong Rak Choi
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion
Abhijit Mazumdar, Graham M. Poage, Jonathan Shepherd, Anna Tsimelzon, Zachary C. Hartman, Petra Den Hollander, Jamal Hill, Yun Zhang, Jenny Chang, Susan G. Hilsenbeck, Suzanne Fuqua, C. Kent Osborne, Gordon B. Mills, Powel H. Brown
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer
Juan Zhang, Jie Sun, Jiuan Chen, Lu Yao, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
Taru A. Muranen, Nasim Mavaddat, Sofia Khan, Rainer Fagerholm, Liisa Pelttari, Andrew Lee, Kristiina Aittomäki, Carl Blomqvist, Douglas F. Easton, Heli Nevanlinna
Characteristics and prognosis of interval cancers after biennial screen-film or full-field digital screening mammography
Roy J. P. Weber, Rob M. G. van Bommel, Marieke W. Louwman, Joost Nederend, Adri C. Voogd, Frits H. Jansen, Vivianne C. G. Tjan-Heijnen, Lucien E. M. Duijm
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
Z. A. Nahleh, W. E. Barlow, D. F. Hayes, A. F. Schott, J. R. Gralow, W. M. Sikov, E. A. Perez, S. Chennuru, H. R. Mirshahidi, S. W. Corso, D. L. Lew, L. Pusztai, R. B. Livingston, G. N. Hortobagyi
Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial
Scott C. Adams, Roanne J. Segal, Donald C. McKenzie, James R. Vallerand, Andria R. Morielli, John R. Mackey, Karen Gelmon, Christine M. Friedenreich, Robert D. Reid, Kerry S. Courneya
Effect of a multidiscipline mentor-based program, Be Resilient to Breast Cancer (BRBC), on female breast cancer survivors in mainland China—A randomized, controlled, theoretically-derived intervention trial
Zeng Jie Ye, Mu Zi Liang, Hong Zhong Qiu, Mei Ling Liu, Guang Yun Hu, Yun Fei Zhu, Zhen Zeng, Jing Jing Zhao, Xiao Ming Quan
The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis
Tracy A. Battaglia, Julie S. Darnell, Naomi Ko, Fred Snyder, Electra D. Paskett, Kristen J. Wells, Elizabeth M. Whitley, Jennifer J. Griggs, Anand Karnad, Heather Young, Victoria Warren-Mears, Melissa A. Simon, Elizabeth Calhoun
Ultrasound-guided breast-conserving surgery for early-stage palpable and nonpalpable invasive breast cancer: decreased excision volume at unchanged tumor-free resection margin
W. A. Slijkhuis, E. M. Noorda, H. van der Zaag-Loonen, M. J. Bolster-van Eenennaam, K. E. Droogh-de Greve, W. B. Lastdrager, J. W. C. Gratama
Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors
Orietta Giuliani, Silvia Mancini, Donella Puliti, Nicola Caranci, Alessandra Ravaioli, Rosa Vattiato, Monica Palumbo, Americo Colamartini, Annibale Biggeri, Lauro Bucchi, Dino Amadori, Fabio Falcini
A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women
Giorgio Secreto, Sabina Sieri, Claudia Agnoli, Sara Grioni, Paola Muti, Barnett Zumoff, Milena Sant, Elisabetta Meneghini, Vittorio Krogh
Predictors of enduring clinical distress in women with breast cancer
Deborah N. N. Lo-Fo-Wong, Hanneke C. J. M. de Haes, Neil K. Aaronson, Doris L. van Abbema, Mathilda D. den Boer, Marjan van Hezewijk, Marcelle Immink, Ad A. Kaptein, Marian B. E. Menke-Pluijmers, Anna K. L. Reyners, Nicola S. Russell, Manon Schriek, Sieta Sijtsema, Geertjan van Tienhoven, Mirjam A. G. Sprangers
Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries
Michael T. Halpern, Deborah Schrag
Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study
Anand K. Narayan, Kala Visvanathan, Susan C. Harvey
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials
Adam R. Brentnall, Jack Cuzick, Helen Byers, Corrinne Segal, Caroline Reuter, Simone Detre, Ivana Sestak, Anthony Howell, Trevor J. Powles, William G. Newman, Mitchell Dowsett
Perioperative biology in primary breast cancer: selective targeting of vasopressin type 2 receptor using desmopressin as a novel therapeutic approach
Juan Garona, Daniel F. Alonso
Mastectomy versus breast conservation treatment: is there a true survival difference?
Mona P. Tan
Retraction Note to: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways
Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Raza Ali, Shadan Ali, Sanjeev Banerjee, Fazlul H. Sarkar
Retraction Note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors
Aamir Ahmad, Zhiwei Wang, Dejuan Kong, Shadan Ali, Yiwei Li, Sanjeev Banerjee, Raza Ali, Fazlul H. Sarkar